| 2024 | 2023 | 2022 | 2021 | 2020 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 144,2 k € | — | — | ||||||||||||||||||
| Gross margin | 282,5 k € | -5.9% | 300,2 k € | -15.7% | 356,1 k € | +37.4% | 259,2 k € | -27.8% | 359,0 k € | +5.9% | 339,1 k € | +1.1% | 335,3 k € | -1.7% | 341,0 k € | +18.6% | 287,6 k € | -16.3% | 343,4 k € | +5.1% | 326,6 k € | -8.6% | 357,6 k € | +16.8% | 306,1 k € | -33.8% | 462,6 k € | +229.0% | 140,6 k € | +77.9% | 79,0 k € | -21.1% | 100,1 k € | +13.6% | 88,1 k € | |
| EBITDA | 279,1 k € | -5.9% | 296,5 k € | -15.6% | 351,2 k € | +38.7% | 253,1 k € | -28.9% | 356,1 k € | +5.9% | 336,1 k € | +1.1% | 332,4 k € | -1.6% | 337,9 k € | +18.6% | 284,8 k € | -16.4% | 340,5 k € | +5.2% | 323,6 k € | -8.6% | 354,1 k € | +16.8% | 303,2 k € | -33.5% | 456,2 k € | +229.7% | 138,4 k € | +80.0% | 76,9 k € | -21.4% | 97,8 k € | +15.4% | 84,7 k € | |
| Operating profit | 227,6 k € | -5.1% | 239,7 k € | -21.8% | 306,5 k € | +47.1% | 208,3 k € | -33.0% | 311,0 k € | +3.8% | 299,6 k € | +1.4% | 295,3 k € | -2.5% | 302,8 k € | +21.0% | 250,3 k € | -16.7% | 300,6 k € | +7.1% | 280,6 k € | -8.2% | 305,8 k € | +19.2% | 256,6 k € | -38.1% | 414,6 k € | +294.8% | 105,0 k € | +184.4% | 36,9 k € | -41.3% | 62,9 k € | +26.0% | 49,9 k € | |
| Profit/loss | 176,3 k € | -5.4% | 186,3 k € | +3.8% | 179,5 k € | -9.8% | 199,0 k € | -8.2% | 216,7 k € | +14.5% | 189,2 k € | +8.5% | 174,5 k € | -9.7% | 193,2 k € | +31.2% | 147,3 k € | -19.4% | 182,8 k € | +0.0% | 182,7 k € | -5.4% | 193,2 k € | +17.9% | 163,9 k € | -37.8% | 263,6 k € | +326.0% | 61,9 k € | +315.1% | 14,9 k € | -62.6% | 39,9 k € | +93.7% | 20,6 k € | |
| Equity | 1,2 M € | -1.2% | 1,2 M € | -11.3% | 1,4 M € | +14.8% | 1,2 M € | +19.6% | 1,0 M € | +49.9% | 678,5 k € | -10.6% | 759,2 k € | +29.8% | 584,7 k € | +13.2% | 516,5 k € | +5.6% | 489,2 k € | +21.3% | 403,4 k € | -17.8% | 490,7 k € | +31.7% | 372,5 k € | -8.8% | 408,6 k € | +66.8% | 245,0 k € | +32.1% | 185,5 k € | +1.3% | 183,1 k € | +25.7% | 145,6 k € | |
| Total assets | 1,3 M € | -5.7% | 1,4 M € | -4.0% | 1,5 M € | +13.7% | 1,3 M € | +13.7% | 1,1 M € | +36.0% | 836,0 k € | -11.6% | 945,5 k € | +4.4% | 905,5 k € | +12.0% | 808,6 k € | -0.6% | 813,7 k € | +12.6% | 722,5 k € | -12.2% | 823,0 k € | +12.7% | 730,2 k € | -2.8% | 751,4 k € | +50.0% | 501,0 k € | +7.6% | 465,7 k € | +0.2% | 464,8 k € | +2.1% | 455,4 k € | |
| Cash | 30,2 k € | -63.4% | 82,4 k € | -26.6% | 112,3 k € | -24.4% | 148,6 k € | +39.8% | 106,3 k € | -6.1% | 113,2 k € | +38.2% | 81,9 k € | -45.4% | 149,9 k € | -7.9% | 162,8 k € | -48.1% | 313,7 k € | +39.8% | 224,5 k € | -2.0% | 229,1 k € | +52.1% | 150,6 k € | -43.3% | 265,6 k € | +163.0% | 101,0 k € | +223.6% | 31,2 k € | -66.0% | 91,9 k € | +261.3% | 25,4 k € | |
| Debts | 103,8 k € | -38.6% | 169,0 k € | +143.9% | 69,3 k € | -1.6% | 70,5 k € | -37.3% | 112,5 k € | -8.5% | 122,9 k € | -29.9% | 175,2 k € | -43.4% | 309,5 k € | +10.6% | 279,8 k € | -9.9% | 310,6 k € | +2.2% | 303,9 k € | -1.6% | 308,8 k € | -7.6% | 334,2 k € | +5.7% | 316,3 k € | +37.9% | 229,3 k € | -9.0% | 252,1 k € | -0.5% | 253,4 k € | -9.5% | 279,8 k € | |
Private limited company · Brasschaat · incorporated on 05/01/2000
Private limited company profitable and well capitalised. Cash position declining (-63.4%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
VANDEREYKEN-GUBBELS is a Private limited company incorporated in 2000. Its main activity is: General medical practice activities. Its registered office is in Brasschaat.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette